86 related articles for article (PubMed ID: 29022645)
21. Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation.
Zheng B; Mao JH; Li XQ; Qian L; Zhu H; Gu DH; Pan XD
Sci Rep; 2016 Jul; 6():29415. PubMed ID: 27412013
[TBL] [Abstract][Full Text] [Related]
22. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
23. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
24. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
25. Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma.
Maynard MA; Evans AJ; Hosomi T; Hara S; Jewett MA; Ohh M
FASEB J; 2005 Sep; 19(11):1396-406. PubMed ID: 16126907
[TBL] [Abstract][Full Text] [Related]
26. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
Li YM; Zhou BP; Deng J; Pan Y; Hay N; Hung MC
Cancer Res; 2005 Apr; 65(8):3257-63. PubMed ID: 15833858
[TBL] [Abstract][Full Text] [Related]
27. mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
Wysocki PJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):231-41. PubMed ID: 19379082
[TBL] [Abstract][Full Text] [Related]
28. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
29. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
31. HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma.
Chen F; Deng J; Liu X; Li W; Zheng J
Sci Rep; 2015 Aug; 5():13470. PubMed ID: 26304749
[TBL] [Abstract][Full Text] [Related]
32. Hormone signaling pathways as treatment targets in renal cell cancer (Review).
Czarnecka AM; Niedzwiedzka M; Porta C; Szczylik C
Int J Oncol; 2016 Jun; 48(6):2221-35. PubMed ID: 27035677
[TBL] [Abstract][Full Text] [Related]
33. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
36. Role of the intracellular localization of HIF-prolyl hydroxylases.
Yasumoto K; Kowata Y; Yoshida A; Torii S; Sogawa K
Biochim Biophys Acta; 2009 May; 1793(5):792-7. PubMed ID: 19339211
[TBL] [Abstract][Full Text] [Related]
37. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.
Song W; Yeh CR; He D; Wang Y; Xie H; Pang ST; Chang LS; Li L; Yeh S
Oncotarget; 2015 Aug; 6(22):19290-304. PubMed ID: 26079540
[TBL] [Abstract][Full Text] [Related]
38. Triiodothyronine (T3) induces proinsulin gene expression by activating PI3K: possible roles for GSK-3β and the transcriptional factor PDX-1.
Goulart-Silva F; Serrano-Nascimento C; Texeira SS; Nunes MT
Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):14-9. PubMed ID: 23147208
[TBL] [Abstract][Full Text] [Related]
39. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH
Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104
[TBL] [Abstract][Full Text] [Related]
40. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
